Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Katzenstein

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Opinion in Oncology|February 18, 1998
Advances in the diagnosis and treatment of neuroblastomaH M Katzenstein, S L Cohn
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000
Angiogenesis in neuroblastomaH M Katzenstein, S L Cohn, S Crawford, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Treatment and outcome of 83 children with intraspinal neuroblastoma: the Pediatric Oncology Group experienceH M Katzenstein, P M Kent, W B London, et al.
Bone Marrow Transplantation|April 1, 1997
Haploidentical related umbilical cord blood stem cell transplant in a child with acute non-lymphocytic leukemiaH M Katzenstein, E R Morgan, M Olsewski, et al.
Medical and Pediatric Oncology|July 24, 2001
Antiangiogenic therapy inhibits human neuroblastoma growthH M Katzenstein, H R Salwen, N N Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Effectiveness of the angiogenesis inhibitor TNP-470 in reducing the growth of human neuroblastoma in nude mice inversely correlates with tumor burdenH M Katzenstein, A W Rademaker, C Senger, et al.
Bone Marrow Transplantation|October 23, 1997
Treatment of poor-risk neuroblastoma patients with high-dose chemotherapy and autologous peripheral stem cell rescueS L Cohn, T J Moss, M Hoover, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2000
MYCN expression is not prognostic of adverse outcome in advanced-stage neuroblastoma with nonamplified MYCNS L Cohn, W B London, D Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group studyH M Katzenstein, L C Bowman, G M Brodeur, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Opinion in Oncology|February 18, 1998
Advances in the diagnosis and treatment of neuroblastomaH M Katzenstein, S L Cohn
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000
Angiogenesis in neuroblastomaH M Katzenstein, S L Cohn, S Crawford, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Treatment and outcome of 83 children with intraspinal neuroblastoma: the Pediatric Oncology Group experienceH M Katzenstein, P M Kent, W B London, et al.
Bone Marrow Transplantation|April 1, 1997
Haploidentical related umbilical cord blood stem cell transplant in a child with acute non-lymphocytic leukemiaH M Katzenstein, E R Morgan, M Olsewski, et al.
Medical and Pediatric Oncology|July 24, 2001
Antiangiogenic therapy inhibits human neuroblastoma growthH M Katzenstein, H R Salwen, N N Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Effectiveness of the angiogenesis inhibitor TNP-470 in reducing the growth of human neuroblastoma in nude mice inversely correlates with tumor burdenH M Katzenstein, A W Rademaker, C Senger, et al.
Bone Marrow Transplantation|October 23, 1997
Treatment of poor-risk neuroblastoma patients with high-dose chemotherapy and autologous peripheral stem cell rescueS L Cohn, T J Moss, M Hoover, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2000
MYCN expression is not prognostic of adverse outcome in advanced-stage neuroblastoma with nonamplified MYCNS L Cohn, W B London, D Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group studyH M Katzenstein, L C Bowman, G M Brodeur, et al.
Pageof 1